These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36938815)

  • 1. Predictive factors for progressive fibrosing interstitial lung disease in anti-synthetase syndrome.
    Zhao Y; Zhang C; Su H; Yin X; Liu X; Hou H; Wang G; Li D; Zhang N; Wei W
    Int J Rheum Dis; 2023 May; 26(5):885-894. PubMed ID: 36938815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of natural killer cell depletion in predicting progressive fibrosing interstitial lung disease in idiopathic inflammatory myopathies.
    Shao C; Xia N; Zhen Y; Zhang X; Yan N; Guo Q
    Front Immunol; 2024; 15():1404828. PubMed ID: 38745647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease.
    Fu H; Zheng Z; Zhang Z; Yang Y; Cui J; Wang Z; Xue J; Chi S; Cao M; Chen J
    Clin Rheumatol; 2023 Jul; 42(7):1917-1929. PubMed ID: 36929316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome.
    Zuo Y; Ye L; Chen F; Shen Y; Lu X; Wang G; Shu X
    Front Immunol; 2022; 13():845988. PubMed ID: 35320936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive fibrosing interstitial lung disease: prevalence and clinical outcome.
    Kwon BS; Choe J; Chae EJ; Hwang HS; Kim YG; Song JW
    Respir Res; 2021 Oct; 22(1):282. PubMed ID: 34719401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors of interstitial lung disease progression at sequential HRCT in anti-synthetase syndrome.
    Liu H; Xie S; Liang T; Ma L; Sun H; Dai H; Wang C
    Eur Radiol; 2019 Oct; 29(10):5349-5357. PubMed ID: 30919069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the clinical features of antisynthetase syndrome: a retrospective cohort study in China.
    Wang R; Zhao Y; Qi F; Wu X; Wang Y; Xu Y; Wu Y; Zhang N; Hou H; Sun W; Li X; Wei W
    Clin Rheumatol; 2023 Mar; 42(3):703-709. PubMed ID: 36308573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers.
    Faverio P; Piluso M; De Giacomi F; Della Zoppa M; Cassandro R; Harari S; Luppi F; Pesci A
    Respiration; 2020; 99(10):838-845. PubMed ID: 33264777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
    Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
    Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Mortality in Progressive Fibrosing Interstitial Lung Diseases.
    Chen X; Guo J; Yu D; Jie B; Zhou Y
    Front Pharmacol; 2021; 12():754851. PubMed ID: 34712141
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic and prognostic biomarkers for progressive fibrosing interstitial lung disease.
    Watase M; Mochimaru T; Kawase H; Shinohara H; Sagawa S; Ikeda T; Yagi S; Yamamura H; Matsuyama E; Kaji M; Kurihara M; Sato M; Horiuchi K; Watanabe R; Nukaga S; Irisa K; Satomi R; Oyamada Y
    PLoS One; 2023; 18(3):e0283288. PubMed ID: 36930615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course and risk factors for development and progression of interstitial lung disease in primary Sjögren's syndrome.
    Lee KA; Nam BD; Hwang JH; Kim HS
    Sci Rep; 2023 Jun; 13(1):9189. PubMed ID: 37280251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of CT quantification in progressive fibrosing interstitial lung disease: a deep learning approach.
    Koh SY; Lee JH; Park H; Goo JM
    Eur Radiol; 2024 Jul; 34(7):4195-4205. PubMed ID: 38085286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors for progressive fibrosis in patients with connective tissue disease associated interstitial lung diseases.
    Chiu YH; Spierings J; de Jong PA; Hoesein FM; Grutters JC; van Laar JM; Voortman M
    Respir Med; 2021 Oct; 187():106579. PubMed ID: 34438351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease.
    Nishiyama N; Masuo M; Nukui Y; Tateishi T; Kishino M; Tateishi U; Morota K; Ohbo K; Miyazaki Y
    Respir Investig; 2021 Jan; 59(1):90-98. PubMed ID: 32919933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline.
    Nagy A; Nagy T; Kolonics-Farkas AM; Eszes N; Vincze K; Barczi E; Tarnoki AD; Tarnoki DL; Nagy G; Kiss E; Maurovich-Horvat P; Bohacs A; Müller V
    Front Pharmacol; 2021; 12():778649. PubMed ID: 35002713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).
    Nasser M; Larrieu S; Boussel L; Si-Mohamed S; Bazin F; Marque S; Massol J; Thivolet-Bejui F; Chalabreysse L; Maucort-Boulch D; Hachulla E; Jouneau S; Le Lay K; Cottin V
    Respir Res; 2021 May; 22(1):162. PubMed ID: 34030695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics of patients with antisynthetase syndrome and interstitial pulmonary disease].
    Li W; Li J; Xie WM; Ren YH; Dai HP
    Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(24):1861-1865. PubMed ID: 32575928
    [No Abstract]   [Full Text] [Related]  

  • 19. Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study.
    Denis A; Henket M; Ernst M; Maes N; Thys M; Regnier C; Malaise O; Frix AN; Gester F; Desir C; Meunier P; Louis R; Malaise M; Guiot J
    Front Med (Lausanne); 2022; 9():1024298. PubMed ID: 36530900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease.
    Andersson H; Sem M; Lund MB; Aaløkken TM; Günther A; Walle-Hansen R; Garen T; Molberg Ø
    Rheumatology (Oxford); 2015 Aug; 54(8):1420-8. PubMed ID: 25740830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.